Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$50,775,837
in 5 filings, $50.8M under 10b5-1 plans

Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-03-07 Klinger Shannon Thyme Chief Legal Officer Exercise or conversion · Restricted Stock Units −1,138 10,248
2023-03-02 Hoge Stephen President Sale −1,177 $136.43 $161K 1,630,460
2023-03-02 Klinger Shannon Thyme Chief Legal Officer Sale −459 $136.43 $63K 5,243
2023-03-02 Bancel Stephane Chief Executive Officer Exercise or conversion +40,000 $0.99 $40K 5,451,946
2023-03-02 Bancel Stephane Chief Executive Officer Sale −8,700 $136.44 $1.2M 5,443,246
2023-03-02 Bancel Stephane Chief Executive Officer Sale −17,541 $137.42 $2.4M 5,425,705
2023-03-02 Bancel Stephane Chief Executive Officer Sale −13,659 $138.27 $1.9M 5,412,046
2023-03-02 Bancel Stephane Chief Executive Officer Sale −100 $139.03 $14K 5,411,946
2023-03-02 Bancel Stephane Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −40,000 1,307,155
2023-03-01 Hoge Stephen President Exercise or conversion +2,606 1,631,637
2023-03-01 Hoge Stephen President Exercise or conversion · Restricted Stock Units −2,606 7,819
2023-03-01 Klinger Shannon Thyme Chief Legal Officer Exercise or conversion +930 5,702
2023-03-01 Klinger Shannon Thyme Chief Legal Officer Exercise or conversion · Restricted Stock Units −930 2,791
2023-03-01 Bancel Stephane Chief Executive Officer Exercise or conversion +40,000 $0.99 $40K 5,451,946
2023-03-01 Bancel Stephane Chief Executive Officer Sale −11,319 $134.34 $1.5M 5,440,627
2023-03-01 Bancel Stephane Chief Executive Officer Sale −21,938 $135.26 $3.0M 5,418,689
2023-03-01 Bancel Stephane Chief Executive Officer Sale −5,593 $136.17 $762K 5,413,096
2023-03-01 Bancel Stephane Chief Executive Officer Sale −1,150 $137.03 $158K 5,411,946
2023-03-01 Bancel Stephane Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −40,000 1,347,155
2023-03-01 AFEYAN NOUBAR Director Sale −10,000 $139.00 $1.4M 2,187,209

Page 54 of 66 · 1,314 trades